Cargando…
Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
BACKGROUND: The symptom for identification of pulmonary arterial hypertension (PAH) is dyspnea on exertion, with a concomitant decrease in exercise capacity. Even patients with hemodynamically improved PAH may have impaired exercise tolerance; however, the effect of central and peripheral factors on...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382004/ https://www.ncbi.nlm.nih.gov/pubmed/37260024 http://dx.doi.org/10.1161/JAHA.122.026890 |
_version_ | 1785080584703311872 |
---|---|
author | Tobita, Kazuki Goda, Ayumi Teruya, Koji Nishida, Yuichiro Takeuchi, Kaori Kikuchi, Hanako Inami, Takumi Kohno, Takashi Tashiro, Syoichi Yamada, Shin Satoh, Toru Soejima, Kyoko |
author_facet | Tobita, Kazuki Goda, Ayumi Teruya, Koji Nishida, Yuichiro Takeuchi, Kaori Kikuchi, Hanako Inami, Takumi Kohno, Takashi Tashiro, Syoichi Yamada, Shin Satoh, Toru Soejima, Kyoko |
author_sort | Tobita, Kazuki |
collection | PubMed |
description | BACKGROUND: The symptom for identification of pulmonary arterial hypertension (PAH) is dyspnea on exertion, with a concomitant decrease in exercise capacity. Even patients with hemodynamically improved PAH may have impaired exercise tolerance; however, the effect of central and peripheral factors on exercise tolerance remains unclear. We explored the factors contributing to exercise capacity and ventilatory efficiency in patients with hemodynamically normalized PAH after medical treatment. METHODS AND RESULTS: In total, 82 patients with PAH (age: median 46 [interquartile range, 39–51] years; male:female, 23:59) and mean pulmonary arterial pressure ≤30 mm Hg at rest were enrolled. The exercise capacity, indicated by the 6‐minute walk distance and peak oxygen consumption, and the ventilatory efficiency, indicated by the minute ventilation versus carbon dioxide output slope, were assessed using cardiopulmonary exercise testing with a right heart catheter. The mean pulmonary arterial pressure was 21 (17–25) mm Hg, and the 6‐minute walk distance was 530 (458–565) m, whereas the peak oxygen consumption was 18.8 (14.8–21.6) mLꞏmin(−1)ꞏkg(−1). The multivariate model that best predicted 6‐minute walk distance included peak arterial mixed venous oxygen content difference (β=0.46, P<0.001), whereas the best peak oxygen consumption predictors included peak cardiac output (β=0.72, P<0.001), peak arterial mixed venous oxygen content difference (β=0.56, P<0.001), and resting mean pulmonary arterial pressure (β=−0.25, P=0.026). The parameter that best predicted minute ventilation versus carbon dioxide output slope was the resting mean pulmonary arterial pressure (β=0.35, P=0.041). Quadriceps muscle strength was moderately correlated with exercise capacity (6‐minute walk distance; ρ=0.57, P<0.001; peak oxygen consumption: ρ=0.56, P<0.001) and weakly correlated with ventilatory efficiency (ρ=−0.32, P=0.007). CONCLUSIONS: Central and peripheral factors are closely related to impaired exercise tolerance in patients with hemodynamically normalized PAH. |
format | Online Article Text |
id | pubmed-10382004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103820042023-07-29 Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension Tobita, Kazuki Goda, Ayumi Teruya, Koji Nishida, Yuichiro Takeuchi, Kaori Kikuchi, Hanako Inami, Takumi Kohno, Takashi Tashiro, Syoichi Yamada, Shin Satoh, Toru Soejima, Kyoko J Am Heart Assoc Original Research BACKGROUND: The symptom for identification of pulmonary arterial hypertension (PAH) is dyspnea on exertion, with a concomitant decrease in exercise capacity. Even patients with hemodynamically improved PAH may have impaired exercise tolerance; however, the effect of central and peripheral factors on exercise tolerance remains unclear. We explored the factors contributing to exercise capacity and ventilatory efficiency in patients with hemodynamically normalized PAH after medical treatment. METHODS AND RESULTS: In total, 82 patients with PAH (age: median 46 [interquartile range, 39–51] years; male:female, 23:59) and mean pulmonary arterial pressure ≤30 mm Hg at rest were enrolled. The exercise capacity, indicated by the 6‐minute walk distance and peak oxygen consumption, and the ventilatory efficiency, indicated by the minute ventilation versus carbon dioxide output slope, were assessed using cardiopulmonary exercise testing with a right heart catheter. The mean pulmonary arterial pressure was 21 (17–25) mm Hg, and the 6‐minute walk distance was 530 (458–565) m, whereas the peak oxygen consumption was 18.8 (14.8–21.6) mLꞏmin(−1)ꞏkg(−1). The multivariate model that best predicted 6‐minute walk distance included peak arterial mixed venous oxygen content difference (β=0.46, P<0.001), whereas the best peak oxygen consumption predictors included peak cardiac output (β=0.72, P<0.001), peak arterial mixed venous oxygen content difference (β=0.56, P<0.001), and resting mean pulmonary arterial pressure (β=−0.25, P=0.026). The parameter that best predicted minute ventilation versus carbon dioxide output slope was the resting mean pulmonary arterial pressure (β=0.35, P=0.041). Quadriceps muscle strength was moderately correlated with exercise capacity (6‐minute walk distance; ρ=0.57, P<0.001; peak oxygen consumption: ρ=0.56, P<0.001) and weakly correlated with ventilatory efficiency (ρ=−0.32, P=0.007). CONCLUSIONS: Central and peripheral factors are closely related to impaired exercise tolerance in patients with hemodynamically normalized PAH. John Wiley and Sons Inc. 2023-06-01 /pmc/articles/PMC10382004/ /pubmed/37260024 http://dx.doi.org/10.1161/JAHA.122.026890 Text en © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Tobita, Kazuki Goda, Ayumi Teruya, Koji Nishida, Yuichiro Takeuchi, Kaori Kikuchi, Hanako Inami, Takumi Kohno, Takashi Tashiro, Syoichi Yamada, Shin Satoh, Toru Soejima, Kyoko Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension |
title | Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension |
title_full | Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension |
title_fullStr | Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension |
title_full_unstemmed | Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension |
title_short | Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension |
title_sort | exercise capacity and ventilatory efficiency in patients with pulmonary arterial hypertension |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382004/ https://www.ncbi.nlm.nih.gov/pubmed/37260024 http://dx.doi.org/10.1161/JAHA.122.026890 |
work_keys_str_mv | AT tobitakazuki exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT godaayumi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT teruyakoji exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT nishidayuichiro exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT takeuchikaori exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT kikuchihanako exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT inamitakumi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT kohnotakashi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT tashirosyoichi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT yamadashin exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT satohtoru exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension AT soejimakyoko exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension |